Russell Investments Group, Ltd. Ligand Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 116,254 shares of LGND stock, worth $13.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

116,254

Previous 91,464 27.1%

Holding current value

$13.4 Million

Previous $7.71 Million 51.12%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$82.7 - $110.11 $2.05 Million - $2.73 Million	24,790 Added 27.1%	116,254 $11.6 Million
Q2 2024 Aug 08, 2024	BUY	$68.53 - $87.91 $1.25 Million - $1.61 Million	18,303 Added 25.02%	91,464 $7.71 Million
Q1 2024 May 08, 2024	BUY	$68.64 - $89.2 $3.05 Million - $3.97 Million	44,499 Added 155.25%	73,161 $5.35 Million
Q4 2023 Feb 05, 2024	BUY	$49.57 - $72.63 $562,371 - $823,987	11,345 Added 65.51%	28,662 $2.05 Million
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $1.81 Million - $2.24 Million	-30,777 Reduced 63.99%	17,317 $1.04 Million
Q2 2023 Aug 10, 2023	SELL	$69.53 - $79.33 $580,645 - $662,484	-8,351 Reduced 14.79%	48,094 $3.47 Million
Q1 2023 May 09, 2023	BUY	$65.67 - $77.08 $1.22 Million - $1.43 Million	18,568 Added 49.02%	56,445 $4.15 Million
Q4 2022 Feb 08, 2023	BUY	$61.72 - $96.74 $1.78 Million - $2.79 Million	28,869 Added 320.48%	37,877 $2.53 Million
Q1 2022 May 05, 2022	SELL	$94.99 - $151.56 $736,647 - $1.18 Million	-7,755 Reduced 46.26%	9,008 $1.01 Million
Q4 2021 Jan 21, 2022	SELL	$127.69 - $165.85 $193,194 - $250,931	-1,513 Reduced 8.28%	16,763 $2.59 Million
Q3 2021 Nov 08, 2021	SELL	$102.33 - $144.73 $197,087 - $278,749	-1,926 Reduced 9.53%	18,276 $2.55 Million
Q2 2021 Aug 04, 2021	SELL	$113.03 - $155.64 $872,704 - $1.2 Million	-7,721 Reduced 27.65%	20,202 $2.65 Million
Q1 2021 May 10, 2021	SELL	$99.52 - $215.83 $11.1 Million - $24.1 Million	-111,784 Reduced 80.01%	27,923 $4.26 Million
Q4 2020 Feb 08, 2021	SELL	$80.55 - $106.05 $2.06 Million - $2.72 Million	-25,623 Reduced 15.5%	139,707 $13.9 Million
Q3 2020 Nov 09, 2020	BUY	$89.56 - $126.72 $1.74 Million - $2.46 Million	19,403 Added 13.3%	165,330 $15.8 Million
Q2 2020 Aug 05, 2020	SELL	$68.28 - $123.65 $863,878 - $1.56 Million	-12,652 Reduced 7.98%	145,927 $16.3 Million
Q1 2020 May 06, 2020	BUY	$63.37 - $107.88 $1.15 Million - $1.96 Million	18,147 Added 12.92%	158,579 $11.5 Million
Q4 2019 Jan 29, 2020	BUY	$96.94 - $113.59 $533,363 - $624,972	5,502 Added 4.08%	140,432 $14.6 Million
Q3 2019 Nov 01, 2019	SELL	$86.25 - $120.16 $1.54 Million - $2.15 Million	-17,861 Reduced 11.69%	134,930 $13.4 Million
Q2 2019 Aug 09, 2019	BUY	$107.38 - $129.34 $554,295 - $667,653	5,162 Added 3.5%	152,791 $17.4 Million
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $3.19 Million - $4.29 Million	-30,142 Reduced 16.96%	147,629 $18.6 Million
Q4 2018 Feb 11, 2019	BUY	$128.36 - $272.13 $3.03 Million - $6.42 Million	23,584 Added 15.3%	177,771 $24.1 Million
Q3 2018 Oct 26, 2018	SELL	$211.18 - $274.49 $8.32 Million - $10.8 Million	-39,395 Reduced 20.35%	154,187 $42.3 Million
Q2 2018 Aug 08, 2018	SELL	$150.77 - $207.98 $10.5 Million - $14.5 Million	-69,822 Reduced 26.51%	193,582 $40.1 Million
Q1 2018 May 11, 2018	SELL	$138.63 - $182.62 $9.68 Million - $12.8 Million	-69,838 Reduced 20.96%	263,404 $43.5 Million
Q4 2017 Feb 06, 2018	SELL	$128.36 - $147.04 $2.89 Million - $3.31 Million	-22,506 Reduced 6.33%	333,242 $46.2 Million
Q3 2017 Nov 07, 2017	BUY	$120.91 - $137.94 $43 Million - $49.1 Million	355,748	355,748 $48.4 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Ligand Pharmaceuticals Inc Transaction History